U.S. Capital Wealth Advisors’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,203
Closed -$29.4K 981
2025
Q3
$29.4K Buy
13,203
+2,647
+25% +$6.06K ﹤0.01% 936
2025
Q2
$25.4K Sell
10,556
-1,623
-13% -$3.95K ﹤0.01% 883
2025
Q1
$28.4K Buy
+12,179
New +$24.4K ﹤0.01% 830
2024
Q2
Sell
-26,253
Closed -$65.1K 669
2024
Q1
$65.1K Sell
26,253
-18,662
-42% -$48.6K ﹤0.01% 668
2023
Q4
$126K Buy
+44,915
New +$121K 0.01% 643

Other funds holding ABEV

U.S. Capital Wealth Advisors's ABEV Position: Q4 2025 in Review

U.S. Capital Wealth Advisors sold out of Ambev (ABEV) in Q4 2025, closing a stake of 13,203 shares — an estimated $29.4K sold.

U.S. Capital Wealth Advisors first reported a position in ABEV in Q4 2023 and held it in 5 quarters. The position peaked at $126K in Q4 2023. 374 funds tracked by Wall St. Rank hold ABEV as of Q4 2025.

  • U.S. Capital Wealth Advisors reported no remaining Ambev position as of Q4 2025 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 13,203 Ambev shares in Q4 2025, an estimated $29.4K.
  • U.S. Capital Wealth Advisors first reported a position in Ambev in Q4 2023 and held it in 5 quarters.
  • U.S. Capital Wealth Advisors's Ambev position peaked at $126K in Q4 2023.
  • 374 funds tracked by Wall St. Rank held Ambev as of Q4 2025.

Based on U.S. Capital Wealth Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.